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Abstract
Background: Higher morbidity and mortality rates are seen amongst patients presenting with hyperlactatemia in
the postoperative period. The purpose of this study was to determine the relationship between persistent elevations in
lactate and poor ICU outcome in post-cardiac surgery patients.
Methods: This was a retrospective matched cohort analysis of cardiac surgery patients undergoing bypass and/or valve
surgery in a university hospital centre. Selection criteria were: cardiac bypass and/or valve surgery; admission to the ICU
for > 24 h postoperatively; and peak lactate≥ 3.0 mmol/L. Hyperlactatemic patients were matched to 2 normolactatemic
patients. Multivariable conditional logistic regression was used to determine predictors of hyperlactatemia and mortality.
Results: Four hundred sixty-nine post-cardiac surgery patients were admitted to the ICU for > 24 h. 144 of these
patients had an arterial blood lactate≥ 3.0 mmol/L. Amongst the mortalities, 78.9 % presented with hyperlactatemia.
Independent risk factors predictive of a lactate ≥3.0 mmol/L were preoperative IABP insertion (RR 2.8, CI 1.1–7.2) and
postoperative acute kidney injury (RR 3.2, CI 2.1–5.4). Patients whose lactate concentrations continued to increase >30 h
postoperatively were more likely to die (RR 8.44 CI 2.50–28.53).
Conclusions: The persistence of hyperlactatemia is a more important determinant of postoperative outcome than the
absolute value of the peak lactate concentration. A simple postoperative lactate washout does not sufficiently explain this
lactate accumulation. Mortality is proposed to be secondary to a state of ongoing hypoperfusion.
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Background
A product of anaerobic metabolism, lactate is a bio-
marker and indicator for tissue hypoperfusion and oxy-
gen debt [1, 2]. In anaerobic metabolism, pyruvate is
converted to lactate so that, in conditions of hypoxia,
energy may continue to be derived from glucose. Patho-
logical causes of lactic acidosis include those conditions
causing tissue hypoxia: pulmonary disease leading to
low PO2; circulatory shock with decreased oxygen deliv-
ery; and decreased hemoglobin and oxygen carrying
capacity [3, 4]. Lactic acidosis secondary to hypoxia or
hypoperfusion is known as “type A” lactate acidosis. A
rise in lactate may also be of the “B” type, which is due
to a lack of lactate clearance by the liver and kidneys.
Lactate concentrations are measured regularly in the
intensive care unit (ICU) and elevated blood lactate is a
common finding post-cardiac surgery. In the critically ill
patient, a normal blood lactate is less than 2 mmol/L.
High postoperative serum lactate levels have been previ-
ously associated with an increased risk of postoperative
mortality and poor outcome in both adult and pediatric
cardiac surgery populations [2–10]. Lactate is also a
biomarker and potential prognostic tool in the acute care
setting. In adult surgical patients, greater mortality rates
are seen amongst patients in whom lactate levels
normalize more slowly. Non-normalizing lactate levels
have been associated with a 100 % postoperative mortality
rate [5].* Correspondence: kosar.khwaja@mcgill.ca4Departments of Surgery and Critical Care Medicine, McGill University Health
Centre, 1650 Cedar Ave. L9.411, Montréal, QC H3G 1A4, Canada
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In this matched cohort study, we describe postopera-
tive outcome in a population of hyperlactatemic cardiac
surgery patients. An analysis of the relationship between
hyperlactatemia, time to peak lactate concentrations and
postoperative mortality was performed. The predictors
of elevated lactate were determined and the value of ser-
ial lactate measurements evaluated.
Methods
Study population and matched controls
A retrospective chart review was conducted on patients
undergoing cardiac surgery at the Royal Victoria Hospital
(Montreal, Quebec) from January 2011 to December 2011,
inclusive. Inclusion criteria were: 1) elective or emergent
coronary artery bypass and/or valve surgery, 2) admission
to the ICU for postoperative care > 24 h in duration, 3)
peak arterial blood lactate ≥ 3.0 mmol/L (Fig. 1). Each
hyperlactatemic patient was matched to 2 control patients
selected from cardiac surgery patients whose operation
occurred between January 2010 and December 2012. Cases
and controls were matched for sex, age, surgery type,
Parsonnet score (a risk estimation score of patient pre-
operative factors including diabetes, left ventricular ejec-
tion fraction, re-operative status, and dialysis-dependence)
and 2 preoperative comorbidities associated with mortality
risk—renal failure and peripheral vascular disease. Patients
without matched controls were excluded from analysis
where appropriate.
Data collection
Preoperative data including comorbidities and risk strati-
fication scores were obtained from the hospital’s cardiac
surgery database. Postoperative data was collected from
the intensive care unit database and the hospital’s clin-
ical information system database. Additionally, patients
presenting with lactate ≥ 3.0 mmol/L in the ICU under-
went a chart review. Postoperative data collected was lim-
ited to events occurring during the ICU stay. Mortality
was defined as death during the cardiac surgery hospital
stay. Serial postoperative lactate values for each patient
with arterial blood lactate values ≥ 3.0 mmol/L were
trended to determine the time to the peak lactate value.
This was defined as the number of hours elapsed between
the surgery end-time to the time of peak sample collec-
tion. Preoperative baseline serum creatinine concentra-
tions were recorded to determine the occurrence of new
acute kidney injury using the Acute Kidney Injury
Network (AKIN) stage 1 criteria. Lastly, diagnostic inter-
ventions performed in the ICU such as CT, MRI, echocar-
diogram, or ultrasound were noted.
Statistical methods
Statistical analyses were performed using the SAS System
(SAS 9.3 Institute, Cary, NC). Patient characteristics were
summarized using proportions, medians, and ranges as
appropriate. The data was analysed in two parts. First, a
cohort study of the patients with lactate ≥3.0 mmol/L was
conducted to determine outcomes. This was followed by a
matched cohort study to assess risk factors for hyperlacta-
temia and mortality.
For the cohort study, student’s t-tests or Wilcoxon’s
rank-sum and Kruskal-Wallis tests were used to compare
clinical variables of survivors and non-survivors. Variables
with univariate significance were entered into the Cox Pro-
portional Hazard regression model which assessed the ef-
fect of time to the development of abnormally high serum
lactate levels while controlling for possible confounders. A
categorical variable was created for the 90th percentile for
time to peak lactate concentrations (30 h). Kaplan Meier
Fig. 1 Selection criteria of cases (a) and controls (b) for the matched cohort study
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curves were created to depict the survival curves for those
reaching peak lactate before and after 30 h.
In the matched cohort analysis, Wilcoxon’s rank-sum
and Kruskal-Wallis tests were used to compare clinical
variables between normolactatemic and hyperlactatemic
patients as well as between survivors and non-survivors.
The individually matched cases and controls were ana-
lyzed using conditional logistic regression through the
Cox Proportional Hazard model with strata. Variables with
univariate significance were entered into the model and
predictors for in-hospital mortality were determined.
Generalized estimating equations for binary data were
used to assess the association of elevated serum lactate
levels with postoperative intra-aortic balloon pump
(IABP).
Data are presented as the following, as appropriate:
number (proportion in percentage), median (range), hazard
ratio (95 % CI). A p-value < 0.05 was considered significant.
This study was approved by the McGill University




Postoperative lactate ≥ 3.0 mmol/L was observed in 195
cases out of the 428 patients reviewed. The procedures
performed in the patient population included 279 coron-
ary artery bypass grafts (CABG), 29 aortic valve repairs/re-
placements (AVR), 23 mitral valve repairs/replacements
(MVR), 45 CABG +AVR, 7 CABG +MVR, and 4 MVR +
tricuspid valve repair/replacement. The matched groups
had similar preoperative characteristics for the variables
for which they were matched. Baseline demographics and
preoperative comorbidities of cases and controls are found
in Table 1. Data was non-normally distributed and there-
fore the median was used to describe and compare cases
with controls. Prevalence of preoperative cardiogenic
shock and IABP insertion was higher in patients with
postoperative peak lactate ≥3.0 mmol/L. The matched
controls had a higher frequency of chronic obstructive
pulmonary disease and diabetes mellitus.
Postoperative outcomes
A summary of postoperative complications is presented in
Table 1. The median peak postoperative arterial blood
lactate amongst the cases was 4.6 mmol/L. That of the
matched controls was 2.1 mmol/L. Over 15 % of cases
returned to the operating room (OR) for further interven-
tion: 8 for hemorrhage/re-exploration, 4 for pericardial
effusion, 2 for perforated bowel, 2 for bowel ischemia/ob-
struction, 2 for peripheral ischemia and 1 for left ventricu-
lar assist device. By contrast, only 1.8 % of controls
returned to the OR for hemorrhage/re-exploration. The
use of IABP was more frequently employed in those with
hyperlactatemia (p < 0.0001). A significantly higher occur-
rence of complications such as cardiogenic shock (6.3 %,
p = 0.002), cardiac hemorrhage (6.3 %, p = 0.01), and acute
kidney injury (50.4 %, p < 0.0001) were also observed.
Renal dysfunction was further characterized by comparing
serum creatinine levels. Preoperative baseline serum cre-
atinine levels were similar between both groups but peak
postoperative creatinine was found to be higher in those
presenting with lactate >3.0 mM. No significant difference
was found with respect to the usage of angiography but
Table 1 Comparison of demographics and perioperative course







Gender (male) 93 (64.6 %) 181 (64.6 %) 1.00
Age (years) 70 (43–89) 70 (42–89) 0.81
Parsonnet score 18.3 (0–49.0) 16.5 (0–52.5) 0.28
Renal failurea 22 (15.3 %) 29 (10.4 %) 0.16
Severe peripheral vascular
disease
13 (9 %) 17 (6.1 %) 0.32
Cardiogenic shockb 5 (3.5 %) 1 (0.4 %) 0.02
Preoperative intra-aortic
balloon pump
16 (11.1 %) 10 (3.6 %) 0.004
Chronic obstructive
pulmonary diseasec
10 (6.9 %) 48 (17.1 %) 0.004
Diabetesd 38 (26.4 %) 103 (36.8 %) 0.04
Postoperative characteristics
Peak lactate (mmol/L) 4.6 (3.0–18.0) 2.1 (0.8–2.9) <0.0001
Peak serum creatinine
level (mmol/L)
127 (66–840) 100 (39–1013) <0.0001
Intra-aortic balloon pump 29 (20.1 %) 14 (5 %) <0.0001
Computed tomography
chest /abdomen
4 (2.8 %) 0 0.01
Return to operating room 22 (15.3 %) 5 (1.8 %) <0.0001
Cardiogenic shock 9 (6.3 %) 2 (0.7 %) 0.002
Post-operative cardiac
hemorrhage
9 (6.3 %) 4 (1.4 %) 0.01
Acute kidney injury (AKIN 1) 68 (50.4 %) 73 (26.8 %) <0.0001
Ischemic bowel 1 (0.7 %) 0 0.34
Length of ICU admission
(days)
3 (1–96) 1 (1–29) <0.0001
ICU readmission 12 (8.3 %) 13 (4.7 %) 0.13
Mechanical ventilation (days) 0.89 (0.14–75.5) 0.50 (0.09–11.9) <0.0001
Mortality 15 (10.4 %) 4 (1.4 %) <0.0001
Cases presented with peak lactate ≥3.0 mmol/L in the postoperative ICU
admission while controls had a peak lactate <3.0 mmol/L. Data is expressed
as: number of patients (frequency in percentage) or median (range)
aAcute or chronic renal failure
bWith urinary output <10 cc/hr
cChronic obstructive pulmonary disease on medical treatment
dDiabetes on insulin or oral hypoglycemic agents
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more CT scans of the chest and/or abdomen were con-
ducted for the hyperlactatemic patients.
Among the cases and controls, length of ICU stay,
time on mechanical ventilation and hospital mortality
were measured (Table 1). With respect to these mea-
sures, hyperlactatemic patients had poorer outcomes,
having a longer ICU stay (3 vs. 1 days, p < 0.0001),
greater time on mechanical ventilation (0.89 vs 0.50 days,
p < 0.0001), and higher hospital mortality (p < 0.0001).
The mortality rate amongst hyperlactatemic patients was
10.4 % compared to 1.4 % in the controls. No differences
were found in the length of hospital admission or the
frequency of ICU readmission.
A comparison between survivors and non-survivors was
conducted in the cohort as well as in the matched-control
analyses. Comparative analysis revealed that, among the
cases of hyperlactatemia, non-survivors had a mean Par-
sonnet score of 31.5, compared to a score of 16.75 in survi-
vors (Table 2). Non-survivors were more often patients
with pre-existing renal failure, chronic obstructive pulmon-
ary disease (COPD), hypertension and heart failure. Emer-
gent surgery, longer cardiopulmonary bypass (CPB) time
and requirement for postoperative IABP were also ob-
served to be significantly increased in non-survivors. The
mean CPB time amongst those who died was 153 min
compared to 110 min in those that survived (p = 0.01).
Death was associated with a higher peak lactate (10.2 vs
4.4 mmol/L, p = 0.0002) and a delayed time to peak lactate.
The 90th percentile for time to peak lactate was 30 h. A
significantly greater proportion of non-survivors surpassed
the 90th percentile: in 64.7 % of mortalities, lactate peak
was reached at >30 h (p < 0.0001). On average, hyperlacta-
temic non-survivors attained their peak lactate in 37.6 h
compared to 7.5 h in survivors (p < 0.0001). Again, differ-
ences were noted with respect to renal function. Acute kid-
ney injury was more frequent in non-survivors. Peak
creatinine and percentage rise in postoperative creatinine
were also greater.
Comparative analysis of non-survivors and survivors
in the matched-control population showed that pre-
operative renal failure, severe peripheral vascular disease
and reoperation were associated with mortality while age
and congestive heart failure approached significance
(Table 3). The majority of patients who died presented
with hyperlactatemia (78.9 %) and the 28-day mortality
amongst hyperlactatemic patients was 5.6 % (8/144 pa-
tients). Mortality in the study population was associated
with a higher incidence of postoperative surgical inter-
ventions, IABP and complications such as cardiogenic
shock, cardiac hemorrhage, and renal dysfunction.
Table 2 Comparison of perioperative characteristics of mortality and survival amongst hyperlactatemic patients
Non-survivors (n = 17) Survivors (n = 127) p-value
Pre-operative characteristics
Gender (male) 9 (52.9 %) 84 (66.1 %) 0.29
Age (years) 75 (56–87) 70 (43–89) 0.12
Parsonnet score 31.5 (17.0–49.0) 16.8 (0–46.5) <0.0001
Parsonnet score greater than 31 20 (15.8 %) 9 (52.9 %) 0.001
Operation status (emergency) 3 (17.7 %) 14 (11.5 %) 0.03
Surgery type 0.36
Dialysis 3 (17.7 %) 3 (2.4 %) 0.02
Chronic Obstructive Pulmonary Disease 4 (23.5 %) 6 (4.7 %) 0.02
Congestive Heart Failure 11 (64.7 %) 50 (39.4 %) 0.05
Post-operative characteristics
Cardiopulmonary Bypass time (min) 153 (83–214) 110 (25–302) 0.01
Post-operative Intra-aortic Balloon Pump 8 (47.1 %) 21 (16.5 %) 0.003
Time to peak lactate >30 h 11 (64.7 %) 3 (2.4 %) <0.0001
Time to peak lactate (hours) 37.6 (1.3–385) 7.5 (0.25–755.5) <0.0001
Peak arterial lactate (mmol/L) 10.2 (2.4–18) 4.4 (1.7–13.1) 0.0002
Total Mechanical Ventilation Days 3.14 (0–76.5) 0.89 (0.14–44.1) 0.0001
Acute kidney injury 16 (100 %) 64 (51.6 %) 0.0002
Peak creatinine (μmol/L) 309 (107–738) 119 (66–840) <0.0001
Postoperative rise in creatinine (%) 30 (−80 to 254) 164 (31 to 660) <0.0001
Cases presented with peak lactate ≥3.0 mmol/L in the postoperative ICU admission. Data is expressed as: number of patients (frequency in percentage) or
median (range)
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Predictors of hyperlactatemia and mortality
Conditional logistic regression was used to determine pre-
dictors of hyperlactatemia and mortality. Two factors pre-
dictive of a peak postoperative lactate ≥3.0 mmol/L were
found: insertion of preoperative IABP and postoperative
acute kidney injury. Adjusted hazard ratios are presented
in Table 4. Patients requiring preoperative IABP insertion
were 2.8 times more likely to develop hyperlactatemia
(95 % CI 1.1–7.2). Acute kidney injury was associated with
a hazard ratio of 3.2 (95 % CI 2.1–5.4).
Despite the association between hyperlactatemia and
mortality on univariate analysis, the logistic regression
model conducted did not find lactate ≥3.0 mmol/L to be
a predictor of death. However, when analysing hyperlac-
tatemic patients as a cohort, calculated hazard ratios
showed that a delayed peak in lactate was strongly asso-
ciated with death (Table 5). Patients who exceeded the
90th percentile for time to peak lactate were 8.44 (95 %
CI 2.50–28.53) times more likely to die. Survival curves
illustrate that overall survival outcomes were better in
those who had a shorter duration of lactate rise (Fig. 2).
Other risk factors for mortality were percentage increase
in serum creatinine and Parsonnet score.
Discussion
The relationship between hyperlactatemia and poor out-
come has been established in adult and pediatric popula-
tions. Mortality risk has been associated with both
intraoperative and postoperative hyperlactatemia [2–17].
Lactate levels between 2.0 and 4.4 mmol/L have been re-
ported to be associated with increased postoperative
morbidity and mortality. Debate exists in the literature
regarding which lactate measurement is most indicative
of poor outcome. Some have measured lactate concen-
trations under CPB or peak postoperative lactate while
others have found that lactate levels upon ICU admis-
sion were predictive of outcome [5, 7–13, 15–19]. Other
studies in medical and surgical critical care have re-
ported that better outcomes are observed in the pres-
ence of effective lactate clearance [6, 13, 19–23]. In sum,
different parameters have been used to characterize the
relationship between lactate and poor outcome. Further-
more, evidence exists to suggest that survivors may be
in a metabolic state more favorable for early resolution
of the hyperlactatemic state. It may be that, in critically
ill patients with multi-organ dysfunction, duration of
lactic acidosis has greater predictive value than that of
initial lactate values at first presentation.
Lactate concentration is determined by both the pro-
duction and clearance of lactate. An elevated lactate may
be secondary to a previous state of anaerobic metabol-
ism that has not yet been cleared. Therefore, the actual
metabolic state of the patient may not be determined by
a sole reliance on a lactate concentration. Given that
hepatic and renal clearance is often impaired in the
Table 3 Comparison of survival and non-survival amongst cases







Gender (male) 11 (57.9 %) 263 (64.9 %) 0.62
Age (years) 75 (56–87) 70 (42–89) 0.05
Parsonnet score 30.5 (16.5–49) 16.5 (0–52.5) <0.0001
Congestive heart failure 12 (63.2 %) 170 (41.9 %) 0.06
Renal failurea 9 (47.4 %) 42 (10.4 %) <0.0001
Severe peripheral vascular
disease
5 (26.3 %) 25 (6.2 %) 0.007
Reoperation 3 (15.8 %) 8 (2 %) 0.005
Chronic obstructive
pulmonary diseaseb




15 (78.9 %) 129 (31.8 %) <0.0001
Peak creatinine μmol/L 127 (66–840) 100 (39–1013) <0.0001
Intra-aortic balloon pump 6 (31.6 %) 37 (9.2 %) 0.008
CT chest /abdomen 2 (10.5 %) 2 (0.5 %) 0.01
Return to OR 5 (26.3 %) 22 (5.4 %) 0.005
Cardiogenic shock 5 (26.3 %) 6 (1.5 %) <0.0001
Post-operative cardiac
hemorrhage
2 (10.5 %) 11 (2.7 %) 0.01
Acute kidney injury (AKIN 1) 16 (84.2 %) 125 (32.2 %) <0.0001
Non-obstructive ileus 1 (5.5 %) 2 (0.5 %) 0.13
Ischemic bowel 1 (5.5 %) 0 0.05
Data is expressed as: number of patients (frequency in percentage) or
median (range)
aAcute or chronic renal failure
bCOPD on medical treatment






Diabetes status 0.53 (0.33–0.86) 0.47 (0.28–0.77)
Preoperative intra-aortic
balloon pump
3.0 (1.2–7.3) 2.8 (1.1–7.2)
Acute kidney injury (AKIN 1) 3.1 (2.0–4.7) 3.2 (2.1–5.1)
n = 424
Table 5 Adjusted and unadjusted hazard ratios for mortality in





Time to peak lactate≥ 30 h 8.44 (2.50–28.53) 7.13 (2.17–23.45)
Percent rise in serum creatinine 1.72 (1.15–2.58) 1.40 (1.03–1.90)
Parsonnet score > 31 5.21 (1.07–25.44) 0.80 (0.24–2.65)
n = 128
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critically ill, it is reasonable to instead observe serial lac-
tate measurements. In this study, lactate was followed
until the peak concentration was reached. That is, mea-
surements were followed so long as there was evidence
of a continued imbalance in the production and clear-
ance of lactate. It is expected that time to peak lactate is
a better reflection of ongoing active metabolic dysfunc-
tion in the critically ill. One other study in the literature
by Ranucci et al. is known to have employed a similar
strategy. Theirs was a study of intraoperative anaerobic
metabolism in patients on cardiopulmonary bypass [17].
The results of this study suggest that a single event
of lactate ≥ 3.0 mmol/L is not a reliable predictor of
mortality in post-cardiac surgery patients [24]. Instead
a strong relationship was drawn between a late peak-
ing lactate and mortality. A peak in lactate at >30 h
postoperatively was a highly significant risk factor for
death in our population. This risk was independent of
the absolute concentration of lactate in the blood,
CPB time, Parsonnet score and use of postoperative
IABP. Two other risk factors with a significant
mortality risk were postoperative rise in creatinine
and the Parsonnet score, a risk stratification score
previously studied on patients at our institution [25, 26].
These findings bring clarity to the approach to interpret-
ation of serial lactate measurements in the post-cardiac
surgery patient population.
Both cardiogenic and non-cardiogenic causes for
hyperlactatemia exist in our population. The multiple
logistic regression models performed here for hyper-
lactatemia suggest that kidney dysfunction and re-
quirement for insertion of a preoperative IABP are
associated with increased risk of postoperative hyper-
lactatemia. The pathophysiology of the hyperlactate-
mic state is primarily one of hypoperfusion, resulting
in anaerobic metabolism and lactic acid production.
Meregalli et al. argued that circulatory dysfunction is
present even in critically ill surgical patients without
evidence of shock. It can be inferred that the
presence of hyperlactatemia indicates “occult hypoper-
fusion” in certain patients, thus explaining their in-
creased mortality [23]. Interestingly, in our study,
acute kidney injury in the postoperative period, de-
fined by the 2007 Acute Kidney Injury Network stage
1 criteria, is highly correlated with hyperlactatemia.
From this, we learn that hyperlactatemia is not only a
Fig. 2 Survival curve for cases of lactate≥ 3.0 mmol/L showing survival probability for patients attaining peak lactate in≥ 30 h (triangles) and those
attaining their peak lactate in < 30 h (circles)
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result of decreased oxygen delivery, but that it is also
affected by end organ dysfunction. Interpretation of
lactate trends therefore should take into account such
non-cardiogenic factors.
In the cardiac surgery population specifically, perfusion
deficits are created while on CPB. As core temperature is
increased and CPB is weaned, perfusion of organs
becomes inadequate for demand, resulting in lactic acid-
osis [27]. In a prospective study, length of time on CPB
has been previously suggested to increase the likelihood of
developing a postoperative lactatemia ≥ 5.0 mmol/L [28].
While the perfusion deficits developed during CPB are
undoubtedly contributing to the cardiac surgery patient’s
anaerobic state in the postoperative period, our results
show that CPB time does not have an independent effect
of significance on the development of a postoperative
hyperlactatemia ≥ 3.0 mmol/L. This lack of detection of a
measurable effect of CPB time on lactate elevation may be
due to our lower threshold value for hyperlactatemia.
The lactate produced intraoperatively while on CPB
continues to be detected in the serum postoperatively as it
is cleared by the kidneys and liver. In addition to this post-
operative “washout phenomenon”, perfusion deficits may
persist into the recovery period, leading to lactate persist-
ence. We do observe that this development of late hyper-
lactatemia is associated with higher mortality risk. The
continued lactate production post-CPB is not sufficiently
explained by a post-CPB washout phenomenon. A short
duration of lactate accumulation and an early peak in
serum lactate—in other words, a washout—likely engender
less morbidity and mortality because of the absence of on-
going perfusion deficits. We therefore deduce that a hyper-
lactatemia of significance is the result of a state of ongoing
hypoperfusion, manifesting as a longer duration of lactate
accumulation and a greater rise in serum creatinine.
There are limitations to this study. This retrospective
review included a heterogeneous study population with
different cardiac pathologies and procedures. Data on
the use of inotropes, which remain possible confounders
in this study, were not collected. Only patients with an
ICU stay greater than 24 h were included with the ra-
tionale that the hyperlactatemia in these patients was of
clinical significance. A bias in the cohort analysis may
have resulted from this selection criteria. Note that in
the matched cohort analysis, both the cohort and corre-
sponding controls had an ICU admission >24 h.
To summarise the findings of this study, we highlight the
concept that the duration of hyperlactatemia is a more im-
portant risk factor than the lactate concentration itself. We
propose that persistent elevations in lactate, for which time
to peak lactate is a surrogate measurement, are due to a
state of ongoing hypoperfusion, leading to a significant
increase in mortality risk. This is in contrast to an early
lactate rise which represents a washout phenomenon.
Conclusions
Cardiac surgery patients presenting with late peaking
blood lactate >30 h post-operatively are at increased risk
for poor ICU outcome and mortality. Lactate persistence
is a better measurement of prognosis than peak lactate
in post-CPB patients. Patients under a state of persistent
hypoperfusion, as opposed to a simple post-CPB lactate
washout, are at risk for an increased frequency of major
postoperative complications and mortality.
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